Yosuke Kawashima Shingo Nishikawa Hironori Ninomiya Reiko Yoshida Natsuki Takano Tomoyo Oguri Satoru Kitazono Noriko Yanagitani Atsushi Horiike Fumiyoshi Ohyanagi Yuichi Ishikawa Makoto Nishio
10.2169/internalmedicine.1673-18
Intern Med
2019;58(10):1479-1484.
lynch syndrome msi-h nivolumab
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/31092773/
Adenocarcinoma of Lung / drug therapy Antineoplastic Agents, Immunological / therapeutic use Colorectal Neoplasms, Hereditary Nonpolyposis / complications Lung Neoplasms / drug therapy Nivolumab / therapeutic use
Adenocarcinoma of Lung / drug therapy Antineoplastic Agents, Immunological / therapeutic use Colorectal Neoplasms, Hereditary Nonpolyposis / complications Lung Neoplasms / drug therapy Nivolumab / therapeutic use Case Reports Aged Humans Male Treatment Outcome Antineoplastic Agents, Immunological Nivolumab
PMC6548921
31092773
Lung Adenocarcinoma with Lynch Syndrome and the Response to Nivolumab
2019